GUTS vs. MDXG, ATRC, AORT, CATX, SILK, ATRI, PLSE, KIDS, EMBC, and FNA
Should you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include MiMedx Group (MDXG), AtriCure (ATRC), Artivion (AORT), Perspective Therapeutics (CATX), Silk Road Medical (SILK), Atrion (ATRI), Pulse Biosciences (PLSE), OrthoPediatrics (KIDS), Embecta (EMBC), and Paragon 28 (FNA). These companies are all part of the "surgical & medical instruments" industry.
Fractyl Health (NASDAQ:GUTS) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.
MiMedx Group has higher revenue and earnings than Fractyl Health.
MiMedx Group received 32 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 77.78% of users gave MiMedx Group an outperform vote.
79.2% of MiMedx Group shares are owned by institutional investors. 1.3% of MiMedx Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
In the previous week, MiMedx Group had 1 more articles in the media than Fractyl Health. MarketBeat recorded 1 mentions for MiMedx Group and 0 mentions for Fractyl Health. Fractyl Health's average media sentiment score of 0.00 equaled MiMedx Group'saverage media sentiment score.
Fractyl Health presently has a consensus target price of $22.00, suggesting a potential upside of 238.46%. MiMedx Group has a consensus target price of $12.25, suggesting a potential upside of 75.25%. Given Fractyl Health's higher probable upside, research analysts plainly believe Fractyl Health is more favorable than MiMedx Group.
MiMedx Group has a net margin of 18.63% compared to Fractyl Health's net margin of 0.00%. MiMedx Group's return on equity of 39.42% beat Fractyl Health's return on equity.
Summary
MiMedx Group beats Fractyl Health on 10 of the 13 factors compared between the two stocks.
Get Fractyl Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GUTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Fractyl Health Competitors List
Related Companies and Tools
